Log in to save to my catalogue

Genetic screening in sporadic ALS and FTD

Genetic screening in sporadic ALS and FTD

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5740553

Genetic screening in sporadic ALS and FTD

About this item

Full title

Genetic screening in sporadic ALS and FTD

Publisher

England: BMJ Publishing Group LTD

Journal title

Journal of neurology, neurosurgery and psychiatry, 2017-12, Vol.88 (12), p.1042-1044

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

The increasing complexity of the genetic landscape in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) presents a significant resource and physician training challenge. At least 10% of those diagnosed with ALS or FTD are known to carry an autosomal dominant genetic mutation. There is no consensus on what constitutes a positive...

Alternative Titles

Full title

Genetic screening in sporadic ALS and FTD

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5740553

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5740553

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp-2017-315995

How to access this item